CD274 and cancer: Two classes of anti-cancer drugs have been implicated in the development of linear IgA bullous dermatosis: antimetabolite chemotherapy (i.e., gemcitabine), and ICI targeting PDL-1 (i.e., durvalumab and atezolizumab).